BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BIIB023

Single IV doses of BIIB023 in dose-escalating cohorts

OTHER

Placebo (sterile normal saline)

Single IV dose of Placebo

Trial Locations (6)

Unknown

Research Site, Anniston

Research Centre, Palm Desert

Research Site, Oklahoma City

Research Centre, Duncansville

Research Centre, Moscow

Research Centre, Yaroslavl

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY